N@N

FIRE, QCOR Expected to Trade Up After Bullish Patterns Develop

September 26, 2011 / M2 PRESSWIRE / BUYINS.NET / http://www.squeezetrigger.com is monitoring top technical trading patterns and these stocks are the most likely to trade Up in the coming weeks. SOURCEFIRE INC (NASDAQ:FIRE), QUESTCOR PHARMACEUTICALS (NASDAQ:QCOR) are all expected to go Up as Bullish signals have been generated by top technical trading patterns. We monitor these patterns: Support Break, Support Reversal, Breakaway Gap, Measured Gap, Exhaustion Gap, Resistance Break, Resistance Reversal, Saucer Reversal, Volume Climax, Volume Trend, Fibonacci Reversal, Consolidation Breaks, Trend Line Break,Trend Line Reversal, Candles, Golden Crosses, Death Crosses and more. The chart below displays the stocks expected to go Up along with pattern, strategy and strength ratings.

     Symbol     Company                             Strategy                            Pattern Name            Strength  
     FIRE       SOURCEFIRE INC                      VWAP Bounce EOD                     Trend Line Break(3)     4         
     QCOR       QUESTCOR PHARMACEUTICALS            NSP-41 NN HTC (+2)                  Three Outside Up        5         

Chart Pattern Recognition is based on a 20-year patterns database. This database is used to determine pattern strength for patterns as they appear. There is no optimization and the pattern signals never change. For each pattern variation, we record accuracy and profitability statistics in a patterns database. From this information, we are able to define strength ratings from 1 to 5. The '1' rating shows ALL patterns while a '5' rating shows the best patterns according to profitability. Each pattern has its own strength rating factors. The result is an automatic ranking system that allows us to only show the BEST patterns. You can see that, at Strength 5, virtually all the patterns are profitable. The pattern strength rating system separates the most profitable patterns. The specific technology used to make these predictions is available for a low monthly fee at: http://www.squeezetrigger.com/services/sw/ot.php

SOURCEFIRE INC (NASDAQ:FIRE) - Sourcefire, Inc. provides intelligent Cybersecurity solutions for information technology (IT); environments of commercial enterprises, such as healthcare, financial services, manufacturing, energy, education, retail, and telecommunications; and federal, state, and international government organizations worldwide. Its Sourcefire 3D System comprising multiple Sourcefire hardware and software product offerings provides an approach to network protection with a layered security defense, protecting computer network assets before, during, and after an attack. The company also offers Snort, an open source intrusion prevention technology that is incorporated into the intrusion prevention system software component of the Sourcefire 3D System; and ClamAV, an open source anti-virus and anti-malware project. In addition, it provides various services to aid customers with installing and supporting Cybersecurity solutions, including customer support, education, professional services, the Sourcefire vulnerability research team, and Snort rule subscriptions. The company has strategic relationships with various managed security service providers, including BT Counterpane, SecureWorks, Symantec, VeriSign, and Verizon Business to provide alternative distribution channels for its products. Sourcefire, Inc. was founded in 2001 and is headquartered in Columbia, Maryland.

QUESTCOR PHARMACEUTICALS (NASDAQ:QCOR) - Questcor Pharmaceuticals, Inc., a pharmaceutical company, provides prescription drugs for central nervous system and inflammatory disorders. Its primary drug is H.P. Acthar Gel (repository corticotropin injection), an injectable drug that is approved for the treatment of certain disorders with an inflammatory component, including the treatment of exacerbations associated with multiple sclerosis, infantile spasms, opsoclonus myoclonus syndrome, and nephrotic syndrome. The company also markets Doral (quazepam), which is indicated for the treatment of insomnia characterized by difficulty in falling asleep, frequent nocturnal awakenings, and/or early morning awakenings. Questcor Pharmaceuticals, Inc. was founded in 1990 and is headquartered in Union City, California.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net